Autoimmune-associated hemophagocytic syndrome

Area of Science:

• Immunology
• Hematology
• Pathology

Background:

• Hemophagocytic syndrome (HPS) is a rare but serious condition involving immune cell overactivation.
• HPS is typically linked to infections or malignancies.
• Recent observations highlight HPS occurrence in patients with autoimmune diseases, independent of infection or malignancy.

Purpose of the Study:

• To review the clinical features, underlying mechanisms, diagnostic criteria, and therapeutic strategies for autoimmune-associated hemophagocytic syndrome (AAHS).
• To consolidate current understanding and literature data on AAHS.

Main Methods:

• Literature review of case reports and studies on AAHS.
• Analysis of clinical data from patients with autoimmune diseases who developed HPS.
• Synthesis of information on pathogenesis, diagnosis, and treatment.

Main Results:

• Autoimmune-associated hemophagocytic syndrome (AAHS) is increasingly recognized as a distinct entity.
• AAHS is associated with active autoimmune disease, lacking evidence of infection or malignancy.
• Clinical presentations, diagnostic challenges, and treatment outcomes for AAHS are being elucidated.

Conclusions:

• AAHS represents a significant subtype of hemophagocytic syndrome.
• Early recognition and appropriate management are crucial for improving outcomes in AAHS patients.
• Further research is needed to fully understand the pathogenesis and optimize treatment for AAHS.